Informations générales (source: ClinicalTrials.gov)
Identification of Susceptibility Loci and Genes for Systemic Vasculitis Risk, by Analyzing Whole Exome Sequencing of Familial and Pediatric Forms of Vasculitis (FAMILYVASC Study) (FAMILYVASC)
Observational
Benjamin Terrier (Voir sur ClinicalTrials)
juin 2019
juin 2029
29 juin 2024
The FAMILYVASC study is a prospective observational study which will aim to identify
susceptibility loci and genes for systemic vasculitis risk in patients with familial or
pediatric forms of vasculitis. Genetic analysis based on whole exome sequencing will be
carried out through salivary DNA.
Etablissements
| Les établissements d'Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
|---|---|---|---|---|---|
| EFS IDF SITE COCHIN | Benjamin Terrier, MD, PhD | Contact (sur clinicalTrials) | |||
Critères
Tous
Inclusion criteria for subjects with vasculitis
- Children and adults
- Patients with vasculitis, as defined in the Chapel Hill International Classification
in its revised version of 2012
- Patient information and signed informed consent
- Pregnant and breastfeeding women can be included in the study
Inclusion criteria for healthy subjects
- Children and adults
- Do not have vasculitis, as defined in the Chapel Hill International Classification
in its revised version of 2012, or relatives on the 1st; 2nd; 3rd or 4th degree of a
patient with vasculitis
- Patient information and signed informed consent
- Pregnant and breastfeeding women can be included in the study
Exclusion criteria:
- Refusal of consent or inability to obtain consent
- Dementia or unauthorized patient, for psychiatric or intellectual failure reasons,
to receive information about the protocol and to give informed consent.
- Uncooperative patient, or any pathology that could make the patient potentially
non-compliant to the study procedures, and patients interned for regulatory or legal
reasons.
- Children and adults
- Patients with vasculitis, as defined in the Chapel Hill International Classification
in its revised version of 2012
- Patient information and signed informed consent
- Pregnant and breastfeeding women can be included in the study
Inclusion criteria for healthy subjects
- Children and adults
- Do not have vasculitis, as defined in the Chapel Hill International Classification
in its revised version of 2012, or relatives on the 1st; 2nd; 3rd or 4th degree of a
patient with vasculitis
- Patient information and signed informed consent
- Pregnant and breastfeeding women can be included in the study
Exclusion criteria:
- Refusal of consent or inability to obtain consent
- Dementia or unauthorized patient, for psychiatric or intellectual failure reasons,
to receive information about the protocol and to give informed consent.
- Uncooperative patient, or any pathology that could make the patient potentially
non-compliant to the study procedures, and patients interned for regulatory or legal
reasons.